The peptide correction of neurotic disorders among professional truck-drivers
A. S. Bashkireva, V. G. Artamonova · 2012 · Adv Gerontol. 25(4):718–728
What does this source report?
The abstract describes occupational psychoemotional differences and reports changes with peptide bioregulators, including combined Pinealon and Vezugen.
- Population and setting
- 150 male lorry drivers and 150 male metal craftsmen in the occupational comparison
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The occupational cohort size is not a verified randomized-treatment sample size.
- Randomization, blinding, and intervention-group sizes are not established from the abstract.
- Combination findings do not identify either peptide’s independent contribution or demonstrate fewer driving accidents.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
PubMed record and English abstract checked; intervention allocation and full methods not reviewed.
Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.
Cite and trace this record
Original source: A. S. Bashkireva, V. G. Artamonova. The peptide correction of neurotic disorders among professional truck-drivers Adv Gerontol. 25(4):718–728 2012.
Molekul research summary: https://molekul.io/research/peptides-2012-drivers. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pinealon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Vesugen
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.